PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1503390
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1503390
According to Stratistics MRC, the Global Endoscopy Devices Market is accounted for $31.9 billion in 2024 and is expected to reach $46.8 billion by 2030 growing at a CAGR of 6.6% during the forecast period. Endoscopy devices are specialized medical instruments used to visualize, diagnose, and perform therapeutic interventions within the body's internal organs and cavities. These devices typically consist of a flexible tube with a light and a camera at the end, allowing for minimally invasive procedures. They are commonly employed in gastroenterology, pulmonology, and gynecology to inspect areas such as the gastrointestinal tract, respiratory system, and reproductive organs.
According to the World Health Organization (WHO), there are an estimated 2 million different kinds of medical devices on the world market, categorized into more than 7,000 generic device groups.
Increasing prevalence of chronic diseases
The rising prevalence of chronic diseases such as gastrointestinal disorders, cancer, and cardiovascular diseases is a significant driver for the endoscopy devices market. These conditions often require diagnostic and therapeutic endoscopic procedures, leading to increased demand for endoscopy devices. The ability of endoscopic procedures to provide minimally invasive solutions with quicker recovery times and fewer complications further boosts their adoption, driving market growth.
High cost of endoscopic equipment
The high cost of endoscopic equipment is a major restraint for the market. Advanced endoscopic devices and systems, such as high-definition visualization systems and robotic-assisted endoscopes, come with substantial price tags. This can limit their adoption, especially in developing regions with budget constraints. The high initial investment and maintenance costs can also be a barrier for smaller healthcare facilities, impacting overall market growth.
Shift towards personalized medicine
The shift towards personalized medicine presents a significant opportunity for the endoscopy devices market. Personalized medicine involves tailoring medical treatment to the individual characteristics of each patient, which requires precise diagnostic tools. Endoscopy devices, with their ability to provide detailed internal views and targeted biopsies, are well-suited for personalized diagnostic and therapeutic procedures. This trend is expected to drive innovation and adoption of advanced endoscopic technologies.
Lack of skilled professionals
The lack of skilled professionals is a notable threat to the endoscopy devices market. Endoscopic procedures require highly trained and experienced healthcare professionals to ensure accurate diagnosis and effective treatment. The shortage of trained endoscopists and technicians can limit the optimal utilization of advanced endoscopy equipment, leading to underperformance and potential complications. This shortage also hampers the adoption of new technologies, restraining market growth.
The Covid-19 pandemic had a significant impact on the endoscopy devices market. During the early stages of the pandemic, elective procedures, including many endoscopic examinations, were postponed or canceled to prioritize resources for Covid-19 patients and reduce the risk of viral transmission. This led to a temporary decline in demand for endoscopy devices. However, as healthcare systems adapted and implemented safety measures, the market began to recover, driven by the resumption of postponed procedures and increased awareness of the importance of early diagnosis.
The endoscopes segment is expected to be the largest during the forecast period
The endoscopes segment is expected to be the largest during the forecast period. Endoscopes are the primary tools used in endoscopic procedures, providing direct visualization of internal organs and tissues. The increasing prevalence of chronic diseases and the growing preference for minimally invasive procedures drive the demand for endoscopes. Technological advancements, such as high-definition imaging and flexible endoscopes, further enhance their utility and adoption, contributing significantly to market growth.
The ambulatory surgery centers (ASCs) segment is expected to have the highest CAGR during the forecast period
The ambulatory surgery centers (ASCs) segment is expected to have the highest CAGR during the forecast period. ASCs offer cost-effective and efficient alternatives to hospital-based surgeries, providing outpatient surgical services. The increasing preference for minimally invasive procedures, which can be performed in ASCs, drives the demand for endoscopy devices in these settings. The convenience, reduced hospital stay, and lower costs associated with ASCs make them an attractive option for patients and healthcare providers, fueling market growth.
The North America region is positioned to dominate the Endoscopy Devices Market. Factors such as advanced healthcare infrastructure, high adoption of medical technologies, and a growing incidence of gastrointestinal and chronic diseases contribute to the region's market leadership. The presence of key market players and favorable reimbursement policies for endoscopic procedures further supports market growth in North America.
The Asia Pacific region anticipates rapid growth in the Endoscopy Devices Market. The region's growth is driven by increasing healthcare investments, improving medical infrastructure, and rising awareness of early diagnosis and treatment. The high prevalence of chronic diseases, coupled with a growing geriatric population, boosts the demand for endoscopic procedures. Additionally, the adoption of advanced endoscopic technologies and the expansion of healthcare services in emerging economies like China and India contribute to the region's high growth rate.
Key players in the market
Some of the key players in Endoscopy Devices Market include Olympus Corporation, KARL STORZ SE & Co. KG, Boston Scientific Corporation, Johnson & Johnson (Ethicon), Stryker Corporation, Medtronic plc, Fujifilm Holdings Corporation, HOYA Corporation, Nipro Corporation, Smith & Nephew plc, Intuitive Surgical, Inc., Richard Wolf GmbH, Cook Medical, B. Braun Melsungen AG, ConMed Corporation, Ambu A/S, CapsoVision, Inc., Fortimedix Surgical B.V., The Cooper Companies, Inc. and Laborie Medical Technologies Inc.
In April 2024, Asensus Surgical, Inc. a medical device company that is digitizing the interface between the surgeon and the patient, announced that it has entered into a non-binding letter of intent (the "letter of intent") with KARL STORZ SE & Co. KG, an independent, family-owned global medical technology company ("KARL STORZ") to engage in diligence and negotiations regarding the terms of a potential transaction whereby KARL STORZ may acquire Asensus. Entry into the letter of intent follows an extensive period of consideration of various strategic alternatives by Asensus, including potential collaboration and licensing transactions, a go-it-alone strategy dependent upon raising significant additional equity capital, a sale of the Company and other potential business development transactions.
In March 2024, Scivita Medical Technology Co., Ltd. ("Scivita Medical") and Boston Scientific Corporation, a leading global medical technology company, joined hands again to sign an expanded strategic cooperation arrangement.
In October 2023, Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today the market launch of its next-generation EVIS X1(TM) endoscopy system, which will be on display and demonstrated Oct. 22-24 during the American College of Gastroenterology (ACG) annual meeting in Vancouver, Canada.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.